Dossier
Xaira Therapeutics
Coverage of Xaira Therapeutics in the Nexus archive.
- STAT+: Sanofi names new R&D head as it tries to jumpstart pipeline
Sanofi appointed Paulo Fontoura as global head of R&D to rejuvenate its pipeline under new CEO Belén Garijo. Fontoura, a neurologist with prior roles at Xaira Therapeutics and Roche, replaces Houman Ashrafian, who is leaving for an external opportunity.